148 related articles for article (PubMed ID: 33674940)
1. Very rare lineage switch from acute myeloid leukemia with BCR-ABL1 to B-lymphoblastic leukemia.
Li T; Chen H; Zhang Y; Zeng Y; Zheng L
Ann Hematol; 2021 Jun; 100(6):1635-1636. PubMed ID: 33674940
[No Abstract] [Full Text] [Related]
2. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
[TBL] [Abstract][Full Text] [Related]
3. γ-Catenin-Dependent Signals Maintain BCR-ABL1
Luong-Gardiol N; Siddiqui I; Pizzitola I; Jeevan-Raj B; Charmoy M; Huang Y; Irmisch A; Curtet S; Angelov GS; Danilo M; Juilland M; Bornhauser B; Thome M; Hantschel O; Chalandon Y; Cazzaniga G; Bourquin JP; Huelsken J; Held W
Cancer Cell; 2019 Apr; 35(4):649-663.e10. PubMed ID: 30991025
[TBL] [Abstract][Full Text] [Related]
4. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
[TBL] [Abstract][Full Text] [Related]
5. Ikaros deficiency is associated with aggressive BCR-ABL1 B-cell precursor acute lymphoblastic leukemia independent of the lineage and developmental origin.
Simand C; Keime C; Cayé A; Arfeuille C; Passet M; Kim R; Cavé H; Clappier E; Kastner P; Chan S; Heizmann B
Haematologica; 2022 Jan; 107(1):316-320. PubMed ID: 34587720
[No Abstract] [Full Text] [Related]
6. A near-haploid clone harboring a BCR/ABL1 gene fusion in an adult patient with newly diagnosed B-lymphoblastic leukemia.
Peterson JF; Ketterling RP; Huang L; Finn LE; Shi M; Hoppman NL; Greipp PT; Baughn LB
Genes Chromosomes Cancer; 2019 Sep; 58(9):665-668. PubMed ID: 30790375
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996.
Piciocchi A; Messina M; Elia L; Vitale A; Soddu S; Testi AM; Chiaretti S; Mancini M; Albano F; Spadano A; Krampera M; Bonifacio M; Cairoli R; Vetro C; Colella F; Ferrara F; Cimino G; Bassan R; Fazi P; Vignetti M
Am J Hematol; 2021 Sep; 96(9):E334-E338. PubMed ID: 34048072
[No Abstract] [Full Text] [Related]
8. Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages.
McClellan JS; Dove C; Gentles AJ; Ryan CE; Majeti R
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4074-9. PubMed ID: 25775523
[TBL] [Abstract][Full Text] [Related]
9. BCR-ABL1-negative acute myeloid leukaemia relapsing as BCR-ABL1-positive disease.
Bai S; Hu S
Br J Haematol; 2017 Feb; 176(4):514. PubMed ID: 27982417
[No Abstract] [Full Text] [Related]
10. Rare concomitance of ETV6::RUNX1 and BCR::ABL1p210 in a child diagnosed with B-cell precursor acute lymphoblastic leukemia.
Barbosa TC; Oliveira E; Blunck CB; Maciel A; Bastos A; Bouzada H; Rouxinol ST; Mansur MB; Costa ES; Almeida CW; Emerenciano M
Cancer Genet; 2023 Aug; 276-277():40-42. PubMed ID: 37480760
[No Abstract] [Full Text] [Related]
11. From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia.
Thakral B; Jain N; Tang G; Konoplev S; Vega F; Medeiros LJ; Wang SA
Ann Diagn Pathol; 2021 Aug; 53():151767. PubMed ID: 34118580
[TBL] [Abstract][Full Text] [Related]
12. BCR-ABL1-positive acute myeloid leukaemia relapsing as acute lymphoblastic leukaemia.
Chen X; Chen H
Br J Haematol; 2020 May; 189(4):591. PubMed ID: 31943141
[No Abstract] [Full Text] [Related]
13. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.
Piedimonte M; Ottone T; Alfonso V; Ferrari A; Conte E; Divona M; Bianchi MP; Ricciardi MR; Mirabilii S; Licchetta R; Campagna A; Cicconi L; Galassi G; Pelliccia S; Leporace A; Lo Coco F; Tafuri A
BMC Cancer; 2019 Jan; 19(1):50. PubMed ID: 30630459
[TBL] [Abstract][Full Text] [Related]
14. From the archives of MD Anderson Cancer Center: BCR-ABL1-like B acute lymphoblastic leukemia with IGH/EPOR fusion.
Liu W; Thakral B; Tang G; Wang W; Medeiros LJ; Konoplev S
Ann Diagn Pathol; 2020 Jun; 46():151514. PubMed ID: 32330662
[No Abstract] [Full Text] [Related]
15. Lymphoid blasts with aberrant myeloid marker expression and BCR/ABL1: Is it mixed phenotype acute leukemia or B lymphoblastic leukemia?
Shopsowitz KE; Shah K; Tsui H
Cytometry B Clin Cytom; 2022 Jan; 102(1):73-75. PubMed ID: 33780164
[No Abstract] [Full Text] [Related]
16. Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.
Balatzenko G; Guenova M; Kalinova I; Belcheva M; Hristozova H; Kaleva V
Cancer Genet; 2013 Mar; 206(3):97-101. PubMed ID: 23491079
[TBL] [Abstract][Full Text] [Related]
17. Mucin 4 protein is expressed in B-acute lymphoblastic leukemia and is restricted to BCR::ABL1-positive and BCR::ABL-like subtypes.
Gestrich CK; De Lancy SJ; Kresak A; Sinno MG; Yalley A; Pateva I; Meyerson H; Shetty S; Oduro KA
Hum Pathol; 2023 Jun; 136():75-83. PubMed ID: 37023866
[TBL] [Abstract][Full Text] [Related]
18. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
Geng H; Brennan S; Milne TA; Chen WY; Li Y; Hurtz C; Kweon SM; Zickl L; Shojaee S; Neuberg D; Huang C; Biswas D; Xin Y; Racevskis J; Ketterling RP; Luger SM; Lazarus H; Tallman MS; Rowe JM; Litzow MR; Guzman ML; Allis CD; Roeder RG; Müschen M; Paietta E; Elemento O; Melnick AM
Cancer Discov; 2012 Nov; 2(11):1004-23. PubMed ID: 23107779
[TBL] [Abstract][Full Text] [Related]
19. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.
Gleissner B; Gökbuget N; Bartram CR; Janssen B; Rieder H; Janssen JW; Fonatsch C; Heyll A; Voliotis D; Beck J; Lipp T; Munzert G; Maurer J; Hoelzer D; Thiel E;
Blood; 2002 Mar; 99(5):1536-43. PubMed ID: 11861265
[TBL] [Abstract][Full Text] [Related]
20. High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.
Young FM; Campbell A; Emo KL; Jansson J; Wang PY; Jordan CT; Mullen CA
Biol Blood Marrow Transplant; 2008 Jun; 14(6):622-30. PubMed ID: 18489987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
